Skip to main content
Fig. 1 | BMC Bioinformatics

Fig. 1

From: Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks

Fig. 1

The illustrative diagram of the two-pass random walk with restart on drug-disease heterogenous network. For a candidate association between drug c i and disease d j , a two-pass random walk process is run to compute its final confidence score. The nodes covered in the initial probability distribution are in gold color, and the candidate drug-disease association is represented by dashed line. a The drug-centric random walk process starts from drug c i and all its known associated diseases. b The disease-centric random walk process starts from disease d j and all known associated drugs

Back to article page